John Dyett - Jun 17, 2021 Form 3 Insider Report for FEMASYS INC (FEMY)

Role
Director, 10%+ Owner
Signature
/s/ Kathy Lee-Sepsick, Attorney-in-fact
Stock symbol
FEMY
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
3
Date filed
6/17/2021, 06:33 PM
Next filing
Jun 24, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FEMY Series B Convertible Preferred Stock Jun 17, 2021 Common Stock 948K By Salem Femasys Investors LLC F1, F2
holding FEMY Series C Convertible Preferred Stock Jun 17, 2021 Common Stock 2.27M By Salem Femasys Investors LLC F2, F3
holding FEMY Series C Convertible Preferred Stock Jun 17, 2021 Common Stock 63.7K By the Dyett Family Trust F3
holding FEMY Warrants (Right to Buy) Jun 17, 2021 Common Stock 55.2K $7.25 By Salem Femasys Investors LLC F2, F4
holding FEMY Warrants (Right to Buy) Jun 17, 2021 Common Stock 129K $9.45 By Salem Femasys Investors LLC F2, F5
holding FEMY Warrants (Right to Buy) Jun 17, 2021 Common Stock 12.7K $9.45 By Salem Femasys Investors LLC F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Series B Convertible Preferred Stock are convertible at any time at the holder's election, without payment of additional consideration. Such shares have no expiration date but are expected to convert into Common Stock automatically upon the closing of the Issuer's initial public offering.
F2 Salem Femasys Investors LLC is a limited liability company consisting of 95 members, as of December 31, 2020. Mr. Dyett, acting as manager for Salem Femasys Investors LLC, has sole voting power over the shares held by Salem Femasys Investors LLC, subject to the vote of members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, and shares dispositive power over such shares, which powers may be exercised by members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, with each of the other members. Mr. Dyett disclaims beneficial ownership over the shares held by Salem Femasys Investors LLC, except to the extent of his pecuniary interest therein.
F3 Shares of Series C Convertible Preferred Stock are convertible at any time at the holder's election, without payment of additional consideration. Such shares have no expiration date but are expected to convert into Common Stock automatically upon the closing of the Issuer's initial public offering.
F4 Each warrant is exercisable by the holder in whole or part at any time and from time to time on or before April 16, 2025.
F5 Each warrant is exercisable by the holder in whole or part at any time and from time to time on or before December 14, 2026.
F6 Each warrant is exercisable by the holder in whole or part at any time and from time to time on or before January 6, 2027.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney